• Lingua: Italiano
    • Italiano Italiano
    • English English

CNCCS

MENU
  • Home
  • Collezione composti chimici
    • Raccolta Composti
    • Laboratori
  • Centro malattie rare
    • Aree di Ricerca
    • Malattie Rare
    • Malattie Trascurate e della Povertà
  • Bioeconomy
    • Bioeconomy Rome Edizione 2014
    • Bioeconomy Rome Edizione 2013
    • Bioeconomy Rome Edizione 2012
    • Bioeconomy Rome Edizione 2011
  • Media
    • Stampa
    • Videos 2020
    • Video
  • Politiche e certificazioni
  • Contatti
    • Lavora con Noi

Oxford vaccine up to 90% effective – trials

24 November 2020 Comments (0) Rassegna Stampa  Like

Oxford vaccine up to 90% effective - trials

photo source: ansa.it

ansa.it

Article published on ansa.it – 23/11/2020

Read the original article on ansa.it

 Like Rassegna Stampa Oxford vaccine up to 90% effective – trials

About the Author: info@iwebyou.it

Comments are closed.

Articoli recenti

  • Oxford vaccine up to 90% effective – trials
  • Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • Interview with Matteo Liguori. Research needs time
  • “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»

Contatti

Fax: +39.06.91093654
Mail: info@cnccs

CNCCS Scarl
Collezione Nazionale dei Composti Chimici e Centro Screening
Via Pontina km 30,600 – 00040 Pomezia (RM)

News

  • Oxford vaccine up to 90% effective – trials
  • Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • Interview with Matteo Liguori. Research needs time
  • “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people

Partners